Sharescart Research Club logo
Apollo Green 72 (28.6%)ASK Investment 895 (-3.2%)AVPL 49 (0%)Bootes Impex 775 (-8.8%)CIAL 442 (-0.5%)CSK 254 (-3.1%)ESDS Software 478 (2.8%)Garuda Aerospace 468 (-2.1%)Goodluck Defence 385 (16%)Hero Motors 325 (0%)Hinduja Leyland 248 (0%)ICL Fincorp 25 (0%)Incred Holdings 154 (2.7%)Kineco Limited 3285 (0%)Lava 60 (15.4%)Market Simplified 26 (-7.1%)Matrix Gas 12 (-20%)Motilal Oswal 12.25 (-2%)MSEI 6.35 (-2.3%)NCDEX 368 (-1.6%)NSE 1985 (-2%)Onix Renewable 68 (21.4%)OYO 23 (-4.2%)OYO Assets 9.25 (-7%)Philips India 1250 (0%)Polymatech Electronics 56 (-3.4%)SBI Mutual 768 (-0.9%)Taparia Tools 6050 (0%)VCI Chemical 64 (0%)Zepto 40 (-4.8%)

15 Days Price Change

Invicta Diagnostic IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 21.34 Cr
Profile
Price Range 80  to  85 per share
Profile
Min Investment ₹85
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

We are an innovative diagnostic chain in Mumbai Metropolitan Region (“MMR”) offering comprehensive radiology andpathology solutions. We offer a one-stop solution for pathology and radiology testing services such as imaging (includingradiology), pathology/clinical laboratory and tele-radiology to customers under the brand name “PC Diagnostics” throughour extensive operational network, which consists of 8 diagnostic centres and 1 centralised laboratory across MumbaiMetropolitan Region in the state of Maharashtra. Read More

Basic Info

Face Value 10 per share

Price 80  to  85 per share

P/E (x) 14.4

Sales( Cr.) 30

PAT( Cr.) 5

EPS 5.9

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Ketan Jayantilal Jain Sanket Vinod Jain Rohit Prakash Srivastava Badal Kailash Naredi Jayesh Prakash Jain

Pre Issue Share Holding 91.89%

Post Issue Share Holding 66.69%

Listing Details:

Listing Price: 100

Listing Gain: 15%

Current Price: 65.8

Gain On Issue: 65.8 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Dec 01, 2025
Closing Date Dec 03, 2025
Allotment Dec 04, 2025
Refund Dec 05, 2025
Delivery of Shares Dec 05, 2025
Listing Date Dec 08, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 3200 272,000
Retail (Max) -- -- --
S-HNI (Min) 1 3200 272,000
S-HNI (Max) 3 9600 816,000
B-HNI (Min) 4 12800 1,088,000

Objective of the Issue

1. Funding capital expenditure for purchase of medical equipment towards establishment of new diagnostic centres in Maharashtra 2. General corporate purposes.

Issue

Category Nos Bid Bid (x)
QIB 0 1875200 0x
NII 0 3940800 0x
Retail 0 4361600 0x
EMP 0 0 0x
Total 0 10177600 0x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Invicta Diagnostic Profit & Loss

#(Fig in Cr.) Mar 2024 Mar 2025 TTM
Net Sales 16 30
Other Income 0 0
Total Income 16 30
Total Expenditure 9 21
Operating Profit 7 9
Interest 0 0
Depreciation 2 2
Exceptional Income / Expenses 0 0
Profit Before Tax 5 7
Provision for Tax 1 2
Profit After Tax 4 5
Adjustments -0 -0
Profit After Adjustments 4 5
Adjusted Earnings Per Share 4.5 5.8

Invicta Diagnostic Balance Sheet

#(Fig in Cr.) Mar 2024 Mar 2025
Shareholder's Funds 10 15
Minority's Interest -1 -1
Borrowings 4 4
Other Non-Current Liabilities 1 1
Total Current Liabilities 2 3
Total Liabilities 16 21
Fixed Assets 12 10
Other Non-Current Assets 0 5
Total Current Assets 4 6
Total Assets 16 21

Invicta Diagnostic Cash Flow

#(Fig in Cr.) Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 1
Cash Flow from Operating Activities 6 7
Cash Flow from Investing Activities -9 -5
Cash Flow from Financing Activities 4 -1
Net Cash Inflow / Outflow 1 1
Closing Cash & Cash Equivalent 1 2

Invicta Diagnostic Ratios

# Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.47 5.81
CEPS(Rs) 6.82 8.82
DPS(Rs) 0 0
Book NAV/Share(Rs) 11.57 17.37
Core EBITDA Margin(%) 44.77 30.57
EBIT Margin(%) 32.99 22.57
Pre Tax Margin(%) 32.35 21.81
PAT Margin (%) 24.04 16.38
Cash Profit Margin (%) 36.25 24.66
ROA(%) 23.95 26.57
ROE(%) 39.1 40.48
ROCE(%) 38.55 42.85
Receivable days 19.71 14.01
Inventory Days 9.08 5.44
Payable days -1344.36 -3135.74
PER(x) 0 0
Price/Book(x) 0 0
Dividend Yield(%) 0 0
EV/Net Sales(x) 0.16 0.33
EV/Core EBITDA(x) 0.36 1.05
Net Sales Growth(%) 0 90.11
EBIT Growth(%) 0 30.11
PAT Growth(%) 0 29.54
EPS Growth(%) 0 30.01
Debt/Equity(x) 0.39 0.24
Current Ratio(x) 1.62 2.37
Quick Ratio(x) 1.45 2.18
Interest Cover(x) 51.8 29.51
Total Debt/Mcap(x) 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 88% 0% 0% 0%
Operating Profit CAGR 29% 0% 0% 0%
PAT CAGR 25% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 40% 40% 40% 40%
ROCE Average 43% 41% 41% 41%

Company Contact Information

Invicta Diagnostic Ltd.

Soniya Nilesh Mahajan

022 - 4971 0036

investors@pcdiagnostics.in

1 G F, Plot 217, Ambavat Bhavan N. M Joshi Marg Delisle Road

IPO Lead Manager(s)

Invicta Diagnostic Ltd.

Socradamus Capital Pvt Ltd.

Registrar Info

Invicta Diagnostic Ltd.

Bigshare Services Pvt Ltd

Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093 (old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059 Tel: + 91 21 626 38200 Fax:

91-022-62638200

91-022-62638299

Investor@bigshareonline.com

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp